Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 3076 AL 3090

Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease

Aldaz T, Nigro P, Sánchez-Gómez A, Painous C, Planellas L, Santacruz P, Cámara A, Compta Y, Valldeoriola F, Martí MJ, Muñoz E.

J Neurol. 2019 Jun;266(6):1340-1350. doi: 10.1007/s00415-019-09263-7. Epub 2019 Mar 5.

Irreversible chorea as the initial presentation of polycythemia rubra vera in an elderly woman

Bhattacharjee S.

Neurosciences (Riyadh). 2019 Jan;24(1):61-62. doi: 10.17712/nsj.2019.1.20180301.

Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease

Tabrizi SJ, Ghosh R, Leavitt BR.

Neuron. 2019 Mar 6;101(5):801-819. doi: 10.1016/j.neuron.2019.01.039.

Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials

Müller HP, Huppertz HJ, Dreyhaupt J, Ludolph AC, Tabrizi SJ, Roos RAC, Durr A, Landwehrmeyer GB, Kassubek J.

Parkinsonism Relat Disord. 2019 Jun;63:179-184. doi: 10.1016/j.parkreldis.2019.02.004. Epub 2019 Feb 5.

Human 2-Oxoglutarate Dehydrogenase and 2-Oxoadipate Dehydrogenase Both Generate Superoxide/H(2)O(2) in a Side Reaction and Each Could Contribute to Oxidative Stress in Mitochondria

Jordan F, Nemeria N, Gerfen G.

Neurochem Res. 2019 Oct;44(10):2325-2335. doi: 10.1007/s11064-019-02765-w. Epub 2019 Mar 7.

Inhibition of Amyloid Fibrillation by Small Molecules and Nanomaterials: Strategic Development of Pharmaceuticals Against Amyloidosis

Sharma V, Ghosh KS.

Protein Pept Lett. 2019;26(5):315-323. doi: 10.2174/0929866526666190307164944.

Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review

Husain I, Zameer S, Madaan T, Minhaj A, Ahmad W, Iqubaal A, Ali A, Najmi AK.

Metab Brain Dis. 2019 Aug;34(4):957-965. doi: 10.1007/s11011-019-00400-9. Epub 2019 Mar 8.

Molecular chaperones biochemistry and role in neurodegenerative diseases

Chaari A.

Int J Biol Macromol. 2019 Jun 15;131:396-411. doi: 10.1016/j.ijbiomac.2019.02.148. Epub 2019 Mar 7.

Effects of sulforaphane in the central nervous system

Huang C, Wu J, Chen D, Jin J, Wu Y, Chen Z.

Eur J Pharmacol. 2019 Jun 15;853:153-168. doi: 10.1016/j.ejphar.2019.03.010. Epub 2019 Mar 8.

An Unusual Case of Essential Tremor Deep Brain Stimulation: Where is the Lead?

Spears CC, Almeida L, Okun MS, Deeb W.

Tremor Other Hyperkinet Mov (N Y). 2019 Mar 7;9:617. doi: 10.7916/d8-xj6w-cm53. eCollection 2019.

The therapeutic role of minocycline in Parkinson's disease

Cankaya S, Cankaya B, Kilic U, Kilic E, Yulug B.

Drugs Context. 2019 Mar 6;8:212553. doi: 10.7573/dic.212553. eCollection 2019.

Suicidal ideation and behavior in Huntington's disease: Systematic review and recommendations

Kachian ZR, Cohen-Zimerman S, Bega D, Gordon B, Grafman J.

J Affect Disord. 2019 May 1;250:319-329. doi: 10.1016/j.jad.2019.03.043. Epub 2019 Mar 5.

Small molecules as therapeutic drugs for Alzheimer's disease

Oliver DMA, Reddy PH.

Mol Cell Neurosci. 2019 Apr;96:47-62. doi: 10.1016/j.mcn.2019.03.001. Epub 2019 Mar 12.

The effects of huntingtin-lowering: what do we know so far?

Kaemmerer WF, Grondin RC.

Degener Neurol Neuromuscul Dis. 2019 Mar 8;9:3-17. doi: 10.2147/DNND.S163808. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias